Despite important advances made in the last century, infectious diseases caused by pathogenic microrganisms are still a major threat to human health. This is worsened by the occurrence of new forms of bacterial resistance against antibiotics, that are the main remedy against infectious diseases, and their rapid spreading across bacterial species, pose additional threats to our health. Thus, the necessity to develop new weapons against pathogenic bacteria is widely recognized as a major challenge for modern drug research. Traditional antibiotic discovery procedures have so far focused on inhibiting the main processes of the bacterial cell (replication, transcription, translation, and peptidoglycan synthesis). This review will give an overview of the therapeutic strategies to cure infectious diseases caused by Gram-negative bacteria through the development of inhibitors of Kdo biosynthesis. Kdo is a monsaccharide essential for OM biogenesis, OM being an essential cellular structure shared by all Gram-negative bacteria. Hence, inhibitors of its biosynthesis can have a broad-spectrum antibacterial activit

Cipolla, L., Polissi, A., Airoldi, C., Galliani, P., Sperandeo, P., Nicotra, F. (2009). The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen. CURRENT DRUG DISCOVERY TECHNOLOGIES, 6, 19-33.

The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen

CIPOLLA, LAURA FRANCESCA;POLISSI, ALESSANDRA;AIROLDI, CRISTINA;SPERANDEO, PAOLA;NICOTRA, FRANCESCO
2009

Abstract

Despite important advances made in the last century, infectious diseases caused by pathogenic microrganisms are still a major threat to human health. This is worsened by the occurrence of new forms of bacterial resistance against antibiotics, that are the main remedy against infectious diseases, and their rapid spreading across bacterial species, pose additional threats to our health. Thus, the necessity to develop new weapons against pathogenic bacteria is widely recognized as a major challenge for modern drug research. Traditional antibiotic discovery procedures have so far focused on inhibiting the main processes of the bacterial cell (replication, transcription, translation, and peptidoglycan synthesis). This review will give an overview of the therapeutic strategies to cure infectious diseases caused by Gram-negative bacteria through the development of inhibitors of Kdo biosynthesis. Kdo is a monsaccharide essential for OM biogenesis, OM being an essential cellular structure shared by all Gram-negative bacteria. Hence, inhibitors of its biosynthesis can have a broad-spectrum antibacterial activit
Articolo in rivista - Articolo scientifico
Scientifica
KDO, antibacterial
English
19
33
Cipolla, L., Polissi, A., Airoldi, C., Galliani, P., Sperandeo, P., Nicotra, F. (2009). The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen. CURRENT DRUG DISCOVERY TECHNOLOGIES, 6, 19-33.
Cipolla, L; Polissi, A; Airoldi, C; Galliani, P; Sperandeo, P; Nicotra, F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/7975
Citazioni
  • Scopus 24
  • ???jsp.display-item.citation.isi??? ND
Social impact